Mr. Stuart M. Essig is Independent Director of St. Jude Medical Inc., since 1999. Mr. Essig is currently the Chairman of the Board of Directors of Integra LifeSciences Holdings Corporationrationration, a manufacturer of medical devices and implants, a position he has held since January 2012. Prior to such role, Mr. Essig served as Integra?s Chief Executive Officer from December 1997 until January 2012 and its President from December 1997 until November 2010. In addition, he has served as a director since he joined Integra in December 1997. Prior to joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a managing director. Mr. Essig has also served on the Board of Directors of the Advanced Medical Technology Association, a trade association that represents the medical device industry.
The company has Return on Asset of 10.02 % which means that on every $100 spent on asset it made $10.02 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.48 % implying that it generated $18.48 on every 100 dollars invested.
The company has 3.36 B in debt with debt to equity (D/E) ratio of 0.88 which is OK given its current industry classification. St Jude Medical Inc has Current Ratio of 2.05 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. St Jude Medical Inc [STJ] is traded on New York Stock Exchange in USA. It is located in Saint Paul, MN and employs 15,000 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory